Genmab — December 2016
-
God morgen.
-
Tak jkj. Fantastisk.
-
Plesner og dara tager scenen - https://twitter.com/rachelgravesen/status/805948557509427200
-
Prisen er største hindring for dara i anden linie iflg lægerne
-
Breaking fra J&J - https://twitter.com/janssenus/status/805948194307850240
-
Lyt med her: http://edge.media-server.com/m/p/fatt4nhn
-
-
Der er slides fra review på Genmabs hjemmeside.
-
Der forventes at starte stort forsøg med SC i H2 2017.
-
Hvad var det med med evetuel filling baseret på interimdata i frontline". Hørte jeg galt?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind